Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Public ClinicalTrials.gov record NCT07770841. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Once Daily Oral Semaglutide in Adults With Overweight or Obesity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body weight when compared to 'dummy' tablets (placebo). Results from this study will help select the most optimal lower dose of oral semaglutide that can be used for treating participants living with overweight or obesity.
Study identification
- NCT ID
- NCT07770841
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 11, 2026
- Primary completion
- Feb 21, 2028
- Completion
- Apr 10, 2028
- Last update posted
- Aug 17, 2026
2026 – 2028
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Uni of Alabama at Birmingham | Birmingham | Alabama | 35296 | Not yet recruiting |
| Headlands Research California, LLC | Escondido | California | 92025 | Not yet recruiting |
| National Research Institute - Huntington Park | Huntington Park | California | 90255 | Not yet recruiting |
| Los Angeles Institute for Metabolic Research | Los Angeles | California | 90015 | Not yet recruiting |
| ERG Holding Company, LLC / Evolution Research Group, LLC | Delray Beach | Florida | 33445 | Not yet recruiting |
| ERG Holding Company, LLC / Evolution Research Group, LLC | Fort Myers | Florida | 33192 | Not yet recruiting |
| Jedidiah Clinical Research | Tampa | Florida | 33619 | Not yet recruiting |
| East West Med Res Inst | Honolulu | Hawaii | 96814 | Not yet recruiting |
| L-MARC Research Center | Louisville | Kentucky | 40213 | Not yet recruiting |
| StudyMetrix Research LLC | City of Saint Peters | Missouri | 63303 | Not yet recruiting |
| Jubilee Clinical Research, Inc. | Las Vegas | Nevada | 89106 | Not yet recruiting |
| Corvallis Clinic PC Clinical Research Department | Corvallis | Oregon | 97330-3737 | Not yet recruiting |
| UPA Ctr Weight and Eating Dis | Philadelphia | Pennsylvania | 19104 | Not yet recruiting |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | Not yet recruiting |
| Cedar Health Research | Dallas | Texas | 75251 | Not yet recruiting |
| Selma Medical Associates | Winchester | Virginia | 22601-3834 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
Recently updated Obesity trials
Other public records listing Obesity. Sorted by last update posted; newest first. Not a recommendation.
- NCT07752979: Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities Recruiting
- NCT07792226: ENLIGHT Trial: ESG With Fundal Mucosal Ablation Not yet recruiting
- NCT07783802: A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event Not yet recruiting
- NCT07684144: Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION) Recruiting
- NCT07554638: Incretin Therapies in Obesity-related HFpEF Recruiting
- NCT05921487: Time Restricted Eating to Mitigate Obesity in Veterans With Spinal Cord Injury Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07770841, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 17, 2026 · Synced Aug 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07770841 live on ClinicalTrials.gov.